$XERS

$10.17▲ +0.2% YTD

4 SEC 13D/G filings tracked · Last updated Oct 6, 2026

Filing History

XERS ▲ +0.2% - Xeris Biopharma Holdings, Inc.

CP $10.17▲ +0.2%Oct 6, 2026 · ThinkSabio Blog

$XERS Barclays analyst Jenna Davidner raised the firm's price target on Xeris Biopharma to $14 from $12 and keeps an Overweight rating on the shares…

News

XERS ▼ -0.4% - Xeris Biopharma Holdings, Inc.

CP $10.11▲ -0.4%Oct 6, 2026 · ThinkSabio Blog

$XERS pt 14 @ Barclays from 12…

News

XERS ▼ -0.6% - Xeris Biopharma Holdings, Inc.

CP $8.43▲ -0.6%Sep 9, 2026 · ThinkSabio Blog

$XERS Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for…

SEC 13D/G

$XERS SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks Simplified

$8.11▲ 10.19%Jul 31, 2026 · ThinkSabio Blog

$XERS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #XERS : $8.11 Sector: Healthcare | YTD: 🔼+ 10.19% The SEC disclo…